In his latest newsletter, Dr. Ravnskov tackles the subject of statin drugs and diabetes. Be aware that the statin mania is so out of hand that you’ve got physicians like Dr. Esselstyn not only putting people on cholesterol-free diets, but also putting them on a statin drug. It’s not enough to eliminate cholesterol from their diet, they also have to put them on a drug that cripples the body’s production of cholesterol. And don’t think that the latter action (taking the statin drug) is just a continuation, an extension of the first action (adjusting the diet). Those two actions are worlds apart, and the latter action of prescribing the statin is not just extreme but truly reckless. Now listen to Dr. Ravnskov:
“It is well established that patients with diabetes run a greater risk of developing cardiovascular diseases. In Sweden and in most other countries, cholesterol-lowering treatment is prescribed routinely to all diabetics- whether their cholesterol numbers are high or not, and failure to do so is seen as professional negligence. But there are a number of observations that should have stopped this practice long ago:”
“First, at least fourteen studies have shown that high cholesterol is not a risk factor for patients with diabetes. If you are in doubt, go to chapter 4 in my book “Ignore the Awkward!” There you will find the references to these studies. The reason is probably because high cholesterol protects against infections- a common problem for diabetic patients. As readers of my books know, there is strong evidence that lipoproteins are able to bind and inactivate all kinds of bacteria and virus. You can read more about that in a paper that I published together with Kilmer McCully, the discoverer of the association between high homocysteine and atherosclerosis.”
“A critical and well-informed reader may possibly say that the small effect from statin treatment is not due to cholesterol-lowering, but to their other effects, and this is true. If so, statin treatment perhaps may benefit a diabetic in other ways. But here comes the next warning: Statin treatment may cause diabetes! Several of the statin trials ended up with more diabetics in the treatment group. For instance, in the JUPITER trial, 3 per cent got diabetes, but it was only 2.4 per cent among the controls. The authors wrote that this small risk was more than balanced by the benefits. Then what was the benefit?
In the control group 2.7% died; in the treatment group, the figure was 2.2%. The trial was stopped after less than two years- so excited were they about that small positive result. But, the question is: what would the results have been after 10 years? How many would have gotten diabetes over that longer interval? Here is a clue. Look at this recent report from a study called the Women’s Health Initiative.”
“More than 150,000 US women age 50-79 were followed for 7-12 years. At follow-up about ten per cent of the women were on statin treatment. Almost ten per cent of the statin-treated women had diabetes, but only six per cent among the non-users. And please recall that no statin trial has ever succeeded in lowering mortality for women.”
“There is a logical reason why cholesterol lowering may lead to diabetes. Like all other organs and structures, the insulin-producing cells need cholesterol, and when less cholesterol is available, less insulin is produced. This was recently demonstrated in a Canadian study.”
“What happens with those who already have diabetes when they start statin treatment? We don’t know because nobody has analysed this question.”
“But, is it really wise to treat diabetic patients with a drug that worsens the function of their insulin-producing cells? And is it wise to try to lower the risk of cardiovascular diseases in people by administering a drug that may cause a disease- diabetes- which increases CVD risk? Or which may cause cancer? And what about the long list of other unpleasant side effects?